Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PATL1 divergent transcript (PATL1-DT) is a long non-coding RNA gene located near, and oriented divergently from, the protein-coding gene PATL1. As a lncRNA, PATL1-DT is transcribed but not translated into protein; its precise biological function, molecular targets, and physiological role have not been characterized in the scientific literature or major gene databases to date[5]. There is no evidence that PATL1-DT is a therapeutic target, nor are there disease associations or drugs targeting this transcript currently reported. Existing information distinguishes it from the protein-coding gene PATL1, which is involved in mRNA decapping and processing body assembly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PATL1 divergent transcript (PATL1-DT).